MESA LABORATORIES INC (MLAB) Forecast, Price Target & Analyst Ratings
NASDAQ:MLAB • US59064R1095
87.59 USD
-5.24 (-5.64%)
At close: Mar 5, 2026
87.59 USD
0 (0%)
After Hours: 3/5/2026, 4:30:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MESA LABORATORIES INC (MLAB).
Forecast Snapshot
Consensus Price Target
$106.59
+ 21.69% Upside
Next Earnings Forecast
Release DateMay 26, 2026
PeriodQ4 / 2026
EPS Estimate$0.35
Revenue Estimate66.474M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$106.59
Upside
+ 21.69%
From current price of $87.59 to mean target of $106.59, Based on 9 analyst forecasts
Low
$94.94
Median
$106.59
High
$120.75
Price Target Revisions
1 Month
5.56%
3 Months
10.00%
Price Target Summary
9 analysts have analysed MLAB and the average price target is 106.59 USD. This implies a price increase of 21.69% is expected in the next year compared to the current price of 87.59.
The average price target has been revised upward by 10% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
MLAB was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MLAB.
In the previous month the buy percentage consensus was at a similar level.
MLAB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-08 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-05-30 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2024-10-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-27 | Wells Fargo | Initiate | Underweight |
| 2024-08-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-07-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-04-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-01-04 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 26, 2026
PeriodQ4 / 2026
EPS Estimate$0.35
Revenue Estimate66.474M
Revenue Q2Q6.98%
EPS Q2Q126.47%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
1.07%
Revenue (3 Months)
1.07%
EPS (1 Month)
-3.77%
EPS (3 Months)
-12.82%
Next Earnings Summary
MLAB is expected to report earnings on 5/26/2026. The consensus EPS estimate for the next earnings is 0.35 USD and the consensus revenue estimate is 66.47M USD.
The next earnings revenue estimate has been revised upward by 1.07% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 219.1M 18.88% | 216.187M -1.33% | 240.978M 11.47% | 255.6M 6.07% | 269.44M 5.41% | 276.82M 2.74% | |
| EBITDA YoY % growth | 37.12M 24.69% | 35.261M -5.01% | 42.095M 19.38% | 62.322M 48.05% | 70.074M 12.44% | 68.34M -2.47% | |
| EBIT YoY % growth | 3.3M -29.79% | 3.687M 11.73% | 17.568M 376.48% | 22.695M 29.18% | 27.336M 20.45% | 28.458M 4.10% | |
| Operating Margin | 1.51% | 1.71% | 7.29% | 8.88% | 10.15% | 10.28% | |
| EPS YoY % growth | 0.16 -88.15% | 3.76 2,250.00% | 0.07 -98.14% | 1.97 2,707.43% | 1.61 -17.82% | 2.94 81.90% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.35 126.47% | -0.22 -126.40% | 0.36 -20.67% | 0.39 -39.58% | 0.42 22.06% |
| Revenue Q2Q % growth | 66.474M 6.98% | 63.938M 7.38% | 65.262M 7.45% | 67.483M 3.62% | 69.08M 3.92% |
| EBITDA Q2Q % growth | 16.218M -37.61% | 15.912M 76.39% | 16.014M -3.12% | 16.116M -36.79% | 16.32M 0.63% |
| EBIT Q2Q % growth | 6.63M 351.33% | 3.672M 19.84% | 5.763M 21.99% | 5.916M -25.82% | 6.069M -8.46% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
247.51%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.11%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
47.61%
EBIT Next 5 Year
N/A
MESA LABORATORIES INC / MLAB Forecast FAQ
Can you provide the average price target for MESA LABORATORIES INC stock?
9 analysts have analysed MLAB and the average price target is 106.59 USD. This implies a price increase of 21.69% is expected in the next year compared to the current price of 87.59.
When does MESA LABORATORIES INC (MLAB) report earnings?
MESA LABORATORIES INC (MLAB) will report earnings on 2026-05-26, before the market open.
What are the consensus estimates for MESA LABORATORIES INC (MLAB) next earnings?
The consensus EPS estimate for the next earnings of MESA LABORATORIES INC (MLAB) is 0.35 USD and the consensus revenue estimate is 66.47M USD.
Can you provide the analyst count for MESA LABORATORIES INC stock?
The number of analysts covering MESA LABORATORIES INC (MLAB) is 9.